US5308412A - Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices - Google Patents

Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices Download PDF

Info

Publication number
US5308412A
US5308412A US08/030,912 US3091293A US5308412A US 5308412 A US5308412 A US 5308412A US 3091293 A US3091293 A US 3091293A US 5308412 A US5308412 A US 5308412A
Authority
US
United States
Prior art keywords
chromium
cobalt
substrate
orthopedic implant
wear resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/030,912
Inventor
H. Ravindranath Shetty
Walter H. Ottersberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zimmer Technology Inc
Original Assignee
Zimmer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zimmer Inc filed Critical Zimmer Inc
Priority to US08/030,912 priority Critical patent/US5308412A/en
Assigned to ZIMMER, INC. reassignment ZIMMER, INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: OTTERSBERG, WALTER H., SHETTY, H. RAVINDRANATH
Application granted granted Critical
Publication of US5308412A publication Critical patent/US5308412A/en
Assigned to ZIMMER, INC. reassignment ZIMMER, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRISTOL-MYERS SQUIBB COMPANY
Assigned to ZIMMER TECHNOLOGY, INC. reassignment ZIMMER TECHNOLOGY, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ZIMMER, INC.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/045Cobalt or cobalt alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C8/00Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
    • C23C8/06Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases
    • C23C8/28Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases more than one element being applied in one step
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C8/00Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
    • C23C8/06Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases
    • C23C8/34Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases more than one element being applied in more than one step
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • A61F2/367Proximal or metaphyseal parts of shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • A61F2/3676Distal or diaphyseal parts of shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30317The prosthesis having different structural features at different locations within the same prosthesis
    • A61F2002/30322The prosthesis having different structural features at different locations within the same prosthesis differing in surface structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30682Means for preventing migration of particles released by the joint, e.g. wear debris or cement particles
    • A61F2002/30685Means for reducing or preventing the generation of wear particulates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/3082Grooves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30922Hardened surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30934Special articulating surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0026Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in surface structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00029Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00598Coating or prosthesis-covering structure made of compounds based on metal oxides or hydroxides
    • A61F2310/00622Coating made of chromium oxide or hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/0073Coating or prosthesis-covering structure made of compounds based on metal carbides
    • A61F2310/00754Coating made of chromium carbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00856Coating or prosthesis-covering structure made of compounds based on metal nitrides
    • A61F2310/00886Coating made of chromium nitride
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/92Method or apparatus for preparing or treating prosthetic
    • Y10S623/923Bone

Definitions

  • the present invention relates generally to cobalt-chromium (Co-Cr) based orthopedic implant devices and, more particularly, to a surface hardening process applicable to such devices, wherein surface hardness and wear resistance properties of the implant are enhanced with minimal loss in fatigue strength.
  • Co-Cr cobalt-chromium
  • Cobalt-chromium based alloys have been used for orthopedic applications because of their strength, corrosion resistance, and biocompatability. However, under conditions of sliding wear or articulation of the cobalt-chromium alloy against other surfaces, particularly polymers, metals, ceramics, bone, and bone cement, the cobalt-chromium alloy will produce wear debris from articulating surfaces. Therefore, the surface of the alloys must be hardened in order to minimize wear.
  • surface hardening of cobalt-chromium based orthopedic implants has been achieved by depositing a titanium nitride coating on the surface of the implant, or by ion implantation of the cobalt-chromium substrate.
  • Known surface hardening methods include gas nitriding, chemical salt bath nitriding, plasma or ion nitriding, and ion implantation. Of these methods, gas nitriding exhibits advantages over the other methods in terms of cost and ease of manufacture.
  • gas nitriding permits efficient batch processing of many parts concurrently in a furnace chamber; whereas, the ion implantation method requires line-of-sight bombardment of the workpiece, thereby limiting the dose uniformity and the number of parts that may be processed concurrently.
  • Gas nitriding of titanium based implants is well known.
  • surface hardening of titanium and its alloys has historically been performed by gas nitriding at elevated temperatures in the range of 700° C. to 1200° C. (1292° F. to 2192° F.).
  • a more recent process has been developed for surface hardening titanium alloys at a temperature of about 1100° F. for approximately eight hours.
  • the hardened surface of the titanium implant occurs primarily due to solid solution hardening of the titanium with nitrogen by dissolution. This process is disclosed in detail in U.S. Pat. No. 5,912,323 issued on Mar. 9, 1993, and entitled "METHOD OF SURFACE HARDENING ORTHOPEDIC IMPLANT DEVICES", which disclosure is hereby incorporated by reference.
  • cobalt-chromium based alloys can be strengthened by adding nitrogen into the alloy in the molten state or diffusing nitrogen into the alloy in the solid state.
  • forming gas (15% hydrogen, 85% nitrogen) is utilized in combination with either ammonia or argon.
  • forming gas (15% hydrogen, 85% nitrogen) is utilized in combination with either ammonia or argon.
  • nitrogen embrittlement and decarburization results from the hydrogen which is present in large amounts in dissociated (cracked) ammonia. If decarburization occurs, carbon is lost from the surface of the alloy, thereby decreasing the hardness of the alloy. Consequently, it is desirable to enhance the surface hardness of the cobalt-chromium material without substantial losses in fatigue strength or wear resistance properties.
  • the present invention provides a process for surface hardening an orthopedic implant device made of a cobalt-chromium alloy, wherein the surface hardness of the device is enhanced while maintaining corrosion resistance and fatigue strength.
  • the invention also encompasses orthopedic implant devices in accordance with the claimed process.
  • the process of the present invention enhances the surface hardness of the cobalt-chromium implant device by thermal reaction of nitrogen gas within a specified temperature range. Consequently, surface hardness and wear properties are enhanced with minimal or no loss in fatigue strength More specifically, the use of a pure nitrogen gas at 1-2 psig. positive pressure in a specified temperature range prevents the formation of a substantial CrN layer on the surface that tends to increase surface roughness and brittleness and diminish wear resistance properties in orthopedic implant applications involving articulating joint surfaces. This method achieves enhanced surface hardness and wear properties without experiencing any gross, through-thickness (bulk) change in the nitrogen content of the implant.
  • bulk through-thickness
  • An advantage of the surface hardening method of the present invention is that the surface of an orthopedic implant device made of a cobalt-chromium alloy is hardened without substantially affecting the mechanical, physical, and corrosion properties of the material.
  • Another advantage of the surface hardening method of the present invention is that the method is particularly adapted for use on load bearing prosthesis that contact with metals, ceramics, bone or polymers, due to a significant improvement in wear resistance coupled with minimal or no loss in fatigue strength.
  • a further advantage of the surface hardening method of the present invention is that it permits batch processing of orthopedic implant devices with uniform PG,6 nitrogen dosage, as opposed to "line of sight” processing of parts in an ion implantation process.
  • Another advantage of the surface hardening method of the present invention is that the surface hardened cobalt-chromium alloy exhibits a lower contact angle and better wettability in water and serum solvents than nontreated alloys.
  • Yet another advantage of the surface hardening method of the present invention is that the surface hardened cobalt-chromium alloy exhibits a lower coefficient of friction against ultrahigh molecular weight polyethylene (UHMWPE) with serum lubrication than nontreated alloys.
  • UHMWPE ultrahigh molecular weight polyethylene
  • Still another advantage of the surface hardening method of the present invention is that the method does not compromise the corrosion resistance of the alloy.
  • the invention in one form thereof, provides an orthopedic implant device having enhanced surface hardness and wear resistance properties, wherein the implant comprises a cobalt-chromium substrate, an outer chromium nitride hardened surface layer substantially free of surface roughness, and a hardened diffusion layer underneath the outer surface layer.
  • the hardened diffusion layer comprises a solid solution of nitrogen, oxygen, and carbon and is thicker than the outer layer.
  • the implant is prepared by hardening the surface of the cobalt-chromium substrate by exposing the substrate to an atmosphere of substantially non-diluted molecular nitrogen gas or ionized nitrogen at a process temperature within the range of 500° F. to 2400° F. for a process time duration sufficient to achieve the hardened diffusion layer and the hardened outer surface layer. The process results in enhanced wear properties by substantially avoiding increased surface roughness.
  • the invention further provides, in one form thereof, a method of manufacturing a cobalt-chromium orthopedic implant device having enhanced wear resistance properties.
  • the method includes an initial step of providing a cobalt-chromium substrate in the form of an orthopedic implant device, or component thereof.
  • a surface hardening step is then performed. Specifically, the surface of the cobalt-chromium substrate is hardened by exposing the substrate to an atmosphere of substantially non-diluted molecular nitrogen gas or ionized nitrogen at a process temperature within the range of 500° F. to 2400° F. for a process time duration sufficient to achieve a hardened diffusion layer and a hardened outer surface layer.
  • the surface of the cobalt-chromium substrate is then mechanically polished to get a highly polished smooth surface. The polishing is carried out in such a way that a minimum amount of metal is removed from the surface.
  • the process temperature is approximately 1400° F.
  • the process time duration is approximately forty-eight hours.
  • FIG. 1 is a side view of a femoral component for a hip prosthesis, representing a cobalt-chromium-molybdenum orthopedic implant device of the type to which the surface hardening process of the present invention is applicable;
  • FIG. 2 is a diagrammatic representation of the process steps involved in an exemplary embodiment of the method of the present invention.
  • FIG. 3 is a graph diagram showing the qualitative relationship between process temperature and time, and properties of a cobalt-chromium orthopedic implant device subjected to the surface hardening process of the present invention.
  • an orthopedic implant device 10 fabricated from a cobalt-chromium alloy material and treated in accordance with the surface hardening method of the present invention.
  • cobalt-chromium material as used herein is intended to encompass both cobalt-chromium based alloys and cobalt-chromium-molybdenum alloys, in particular.
  • Two such cobalt-chromium-molybdenum alloys commonly used in orthopedic applications because of their strength, corrosion resistance, and biocompatability are ASTM F-75 and ASTM F-799.
  • ASTM F-75 alloys include The Hayes Stellite 21 the Haynes Stellite 6B (TM) alloy and the Ultimet (TM) alloy.
  • an ASTM F-75 alloy is available having a high carbon and nitrogen content, and is known as Modified ASTM F-75 alloy.
  • orthopedic implant device 10 comprises a femoral component for a hip prosthesis of the type disclosed in U.S. Pat. No. 4,813,963, assigned to the same assignee as the present invention, the disclosure of which is hereby incorporated by reference.
  • femoral component 10 includes a distal end 12, and a proximal end 14 having a neck 16 adapted to carry a ball 18 shown in phantom in FIG. 1.
  • Femoral component 10 is intended to fit within an intramedullary canal of the femur (not shown) such that proximal end 14 extends outwardly from the intramedullary canal of the femur to cooperate with an acetabulum by means of ball 18.
  • Femoral component 10 includes a plurality of longitudinally extending grooves 20 at distal end 12 and a porous surface 22 encircling the femoral component at an intermediate location along femoral component 10.
  • block 30 represents the first step of providing at least one cobalt-chromium orthopedic implant device or component part thereof.
  • ASTM F-75 or ASTM F-799 alloys are used for the implant device in the disclosed embodiment of the invention.
  • Block 32 represents the next step of cleaning the device to remove all residues. Specifically, after an initial cleaning, the orthopedic implant devices are handled with gloved hands. The devices are then ultrasonically cleaned for 30 minutes in isopropyl alcohol and are then spray-dried to obtain a spot-free clean surface.
  • the furnace of the preferred embodiment is a vacuum furnace manufactured by Vacuum Furnace Systems (VFS) Corporation of Souderton, Pa. It is recommended that any furnace used for surface hardening the disclosed cobalt-chromium orthopedic implant devices be capable of maintaining a pressure level of 1 ⁇ 10 -6 Torr, a leak rate not exceeding 5 microns per hour, and a thermal uniformity of ⁇ 25° F. in vacuum and within ⁇ 50° F. in a nitrogen gas atmosphere, at operating temperatures.
  • VFS Vacuum Furnace Systems
  • a furnace load is prepared, consisting of properly cleaned orthopedic implant devices assembled on suitable fixtures.
  • the implant devices may or may not include any preattached bone ingrowth features, assembled on suitable fixtures.
  • the boundaries of the load must not extend beyond the uniform hot zone of the furnace.
  • the number of parts in a load is dependent upon component size and fixture geometry.
  • a predetermined mass of compacted titanium wire is equally divided and placed within and around the load to act as a getter.
  • Cobalt-chromium alloy surface hardening can also be conducted without the getter material. Only materials which do not contaminate the cobalt-chromium alloy may be placed in the furnace with the load. Examples include outgassed high purity graphite, high purity alumina, zirconia, molybdenum, tantalum, and titanium.
  • the next step is pumping down (evacuating) the chamber to 1 ⁇ 10 -5 Torr pressure and then backfilling with high purity nitrogen gas or ionized nitrogen to one atmosphere (or 0 psig), i.e., substantially non-diluted as represented by block 36.
  • non-diluted gas shall include a non-rarefied gas.
  • the step of block 36 is preferably performed at least twice, in order to remove any impurities.
  • the chamber is then purged by once again pumping down or evacuating to 1 ⁇ 10 -5 Torr pressure, as represented by block 38.
  • the minimum purity of molecular nitrogen gas used in the disclosed embodiment of the present invention is preferably 99.998 percent, with maximum allowable impurities of 10 ppm oxygen and 4 ppm water (vapor).
  • the nitrogen gas may contain a trace of argon.
  • the gas should also have a -90° F. dew point.
  • the next step is heating the furnace at a rate of 25° F. per minute to a temperature of 1300° F. ⁇ 50° F. and holding that temperature for 30 minutes to accomplish an equilibrating soak.
  • the next step represented by block 44, is filling the furnace with non-diluted nitrogen gas or ionized nitrogen to a pressure greater than one atmosphere pressure.
  • a preferred range for the attained pressure is a minimum of 1 psig and a maximum of 2 psig; however, process pressure may be varied further without departing from spirit or scope of the invention.
  • Block 46 of FIG. 2 represents the next step of heating the furnace at 20° F. per minute to a process temperature of 1400° F. ⁇ 50° F.
  • an equilibrating soak is performed for 30 minutes at the process temperature.
  • the implant devices are processed for a predetermined process time duration at the process temperature.
  • a surface hardening cycle is run at the process temperature for various time periods depending upon the hardness and thickness of the hardened layer desired from the process.
  • the time period ranges from 8 to 48 hours.
  • the hardening cycle is not considered to begin until any and all monitoring thermocouples are within the specified range for the process temperature.
  • the load may either be nitrogen quenched or furnace cooled, as the implant devices are cooled down, according to the step of block 52.
  • the furnace is not opened until the temperature of the load is stabilized at 200° F. ⁇ 25° F., or less, as measured by the highest reading monitoring thermocouple.
  • the furnace may then be opened and the load removed, after which final passivation and processing is performed according to the steps of blocks 54 and 56, respectively.
  • the final passivation step may also include polishing as shown in block 58.
  • the cobalt-chromium alloy surface hardening method of the present invention can also be conducted at different temperatures in the range of 500° F. to 2400° F. at different nitrogen gas pressures, and for different time periods to produce the characteristic results of the present invention. This is graphically illustrated by the graph diagram of FIG. 3 showing the qualitative relationship between process temperature and time and the properties of cobalt-chromium orthopedic implant devices subjected to the surface hardening process of the present invention.
  • witness coupons of the same alloy and condition as the items in the load are placed in the furnace to assess the outcome of the process.
  • One coupon is placed as closely as possible to the center of the load.
  • the remaining coupons are placed in the hottest and coldest spots in the load as defined by previous survey.
  • the microhardness of the treated coupons is measured with a 2 gram load using a Knoop indentor.
  • the surface hardening process of the present invention has been found to significantly increase the surface hardness of the cobalt-chromium material from its untreated condition.
  • the hardness can be increased up to 5000 KHN depending upon the temperature, time, and nitrogen gas pressure used in the process.
  • the average 2 gram Knoop surface hardness of the cobalt-chromium alloy processed at a process temperature of 1400° F. for a process time of 48 hours is approximately 1000 KHN, while the 2 gram Knoop surface hardness of the untreated alloy is in the range of 300-600 KHN.
  • Nitrogen depth profiles are also performed on the coupons to measure the depth concentration of nitrogen and oxygen, as by Electron Spectroscopy for Chemical Analysis (ESCA).
  • the peak nitrogen concentration falls within the range of 5 atomic percent to 50 atomic percent and occurs at a depth between 100 and 1000 Angstroms from the alloy surface.
  • An example of such a profile is exhibited in Tables I and II for a cobalt-chromium-molybdenum alloy, specifically ASTM F-75, for depths up to 2000 Angstroms (Table I) and 5000 Angstroms (Table II) below the surface of the alloy.
  • the fatigue strength of the cobalt-chromium alloy subjected to the process of the present invention was quantitatively tested by measuring the bending fatigue strength in units of kilopounds/in 2 . It was determined that the disclosed low temperature surface hardening process results in minimal or no loss of fatigue properties.
  • the wear resistance of the cobalt-chromium alloy surface hardened in accordance with the disclosed process was tested by performing wear tests on a pin-on-disk wear tester, using ultrahigh molecular weight polyethylene (UHMWPE), bone, and bone cement pins to simulate actual implant conditions. Significant improvement in both sliding and abrasive wear resistance properties were observed.
  • UHMWPE ultrahigh molecular weight polyethylene
  • treated samples of polished ASTM F-75 were analyzed through an Electron Spectroscopy for Chemical Analysis (ESCA) to identify phases or species present on the surface and to obtain surface chemistry versus depth plots of the samples including various spectra.
  • ESA Electron Spectroscopy for Chemical Analysis
  • the surface hardening process of the disclosed preferred embodiment produces a hardened surface layer, which is limited in thickness to a depth approximately 100 micrometers.
  • the hardened surface layer is believed to include chromium nitride with different stoichiometries. It is also believed to have chromium oxide with different stoichiometries.
  • the hardened surface layer is also believed to have some carbides in the form of chromium carbide.
  • the hardened surface layer is a hardened diffusion region that is hardened due to solid solution hardening of the cobalt-chromium alloy.
  • the solid solution hardening elements in this case are nitrogen, oxygen, and carbon. This region extends several microns from the surface of the device.
  • the ESCA analyses indicate that the hardened surface layer and harder diffusion region together constitute the desired hardened surface.
  • metallurgical changes on the surface of the treated cobalt-chromium implant device include the presence of chromium nitride, chromium oxide, chromium carbide, and solid solution of nitrogen in cobalt-chromium-molybdenum alloy, all of which together produce the desired hardening effect.
  • While the surface hardening process of the present invention is particularly applicable to orthopedic applications involving load bearing prostheses in articulating contact with bone, metals, ceramics or polymers, e.g., hip, knee, ankle, elbow, shoulder, wrist, finger, and toe joints, and may also be used to treat all cobalt-chromium and cobalt-chromium-molybdenum alloy fracture fixation devices as well.

Abstract

A method of surface hardening cobalt-chromium based orthopedic implant devices, and a cobalt-chromium orthopedic implant device prepared by the disclosed method. An orthopedic implant device made of a cobalt-chromium or cobalt-chromium-molybdenum alloy, such as ASTM F-75 or ASTM F-799 is exposed to molecular nitrogen gas or ionized nitrogen at a process temperature and for a process time duration sufficient to enhance surface hardness and wear resistance properties, without the formation of a measurable nitrogen layer that tends to increase surface roughness and brittleness and diminish wear resistance properties. The process temperature is in the range of 500° F. to 2400° F., preferably about 1400° F., and the process time duration at the preferred process temperature is approximately 48 hours. The hardened surface of the cobalt-chromium-molybdenum implant occurs primarily due to nitride formation and solid solution hardening of the cobalt-chromium-molybdenum with nitrogen and oxygen, by dissolution.

Description

BACKGROUND OF THE INVENTION
The present invention relates generally to cobalt-chromium (Co-Cr) based orthopedic implant devices and, more particularly, to a surface hardening process applicable to such devices, wherein surface hardness and wear resistance properties of the implant are enhanced with minimal loss in fatigue strength.
Cobalt-chromium based alloys have been used for orthopedic applications because of their strength, corrosion resistance, and biocompatability. However, under conditions of sliding wear or articulation of the cobalt-chromium alloy against other surfaces, particularly polymers, metals, ceramics, bone, and bone cement, the cobalt-chromium alloy will produce wear debris from articulating surfaces. Therefore, the surface of the alloys must be hardened in order to minimize wear.
In the past, surface hardening of cobalt-chromium based orthopedic implants has been achieved by depositing a titanium nitride coating on the surface of the implant, or by ion implantation of the cobalt-chromium substrate. Known surface hardening methods include gas nitriding, chemical salt bath nitriding, plasma or ion nitriding, and ion implantation. Of these methods, gas nitriding exhibits advantages over the other methods in terms of cost and ease of manufacture. For example, gas nitriding permits efficient batch processing of many parts concurrently in a furnace chamber; whereas, the ion implantation method requires line-of-sight bombardment of the workpiece, thereby limiting the dose uniformity and the number of parts that may be processed concurrently.
Gas nitriding of titanium based implants is well known. For example, surface hardening of titanium and its alloys has historically been performed by gas nitriding at elevated temperatures in the range of 700° C. to 1200° C. (1292° F. to 2192° F.). However, due to undesirable changes of certain physical and mechanical properties of the alloy based upon such high temperatures, a more recent process has been developed for surface hardening titanium alloys at a temperature of about 1100° F. for approximately eight hours. The hardened surface of the titanium implant occurs primarily due to solid solution hardening of the titanium with nitrogen by dissolution. This process is disclosed in detail in U.S. Pat. No. 5,912,323 issued on Mar. 9, 1993, and entitled "METHOD OF SURFACE HARDENING ORTHOPEDIC IMPLANT DEVICES", which disclosure is hereby incorporated by reference.
It is also known that cobalt-chromium based alloys, specifically ASTM F-75 and ASTM F-799 alloys, can be strengthened by adding nitrogen into the alloy in the molten state or diffusing nitrogen into the alloy in the solid state. Specifically, forming gas (15% hydrogen, 85% nitrogen) is utilized in combination with either ammonia or argon. However, such processes actually change the chemistry of the alloy by significantly increasing the weight percent of nitrogen present throughout the alloy. It has been found that when nitrogen is added in this manner, the fracture toughness of the alloy is reduced significantly because of the gross change in the chemistry of the alloy. It has also been found that hydrogen embrittlement and decarburization results from the hydrogen which is present in large amounts in dissociated (cracked) ammonia. If decarburization occurs, carbon is lost from the surface of the alloy, thereby decreasing the hardness of the alloy. Consequently, it is desirable to enhance the surface hardness of the cobalt-chromium material without substantial losses in fatigue strength or wear resistance properties.
SUMMARY OF THE INVENTION
Generally, the present invention provides a process for surface hardening an orthopedic implant device made of a cobalt-chromium alloy, wherein the surface hardness of the device is enhanced while maintaining corrosion resistance and fatigue strength. The invention also encompasses orthopedic implant devices in accordance with the claimed process.
Generally, the process of the present invention enhances the surface hardness of the cobalt-chromium implant device by thermal reaction of nitrogen gas within a specified temperature range. Consequently, surface hardness and wear properties are enhanced with minimal or no loss in fatigue strength More specifically, the use of a pure nitrogen gas at 1-2 psig. positive pressure in a specified temperature range prevents the formation of a substantial CrN layer on the surface that tends to increase surface roughness and brittleness and diminish wear resistance properties in orthopedic implant applications involving articulating joint surfaces. This method achieves enhanced surface hardness and wear properties without experiencing any gross, through-thickness (bulk) change in the nitrogen content of the implant.
An advantage of the surface hardening method of the present invention is that the surface of an orthopedic implant device made of a cobalt-chromium alloy is hardened without substantially affecting the mechanical, physical, and corrosion properties of the material.
Another advantage of the surface hardening method of the present invention is that the method is particularly adapted for use on load bearing prosthesis that contact with metals, ceramics, bone or polymers, due to a significant improvement in wear resistance coupled with minimal or no loss in fatigue strength.
A further advantage of the surface hardening method of the present invention is that it permits batch processing of orthopedic implant devices with uniform PG,6 nitrogen dosage, as opposed to "line of sight" processing of parts in an ion implantation process.
Another advantage of the surface hardening method of the present invention is that the surface hardened cobalt-chromium alloy exhibits a lower contact angle and better wettability in water and serum solvents than nontreated alloys.
Yet another advantage of the surface hardening method of the present invention is that the surface hardened cobalt-chromium alloy exhibits a lower coefficient of friction against ultrahigh molecular weight polyethylene (UHMWPE) with serum lubrication than nontreated alloys.
Still another advantage of the surface hardening method of the present invention is that the method does not compromise the corrosion resistance of the alloy.
The invention, in one form thereof, provides an orthopedic implant device having enhanced surface hardness and wear resistance properties, wherein the implant comprises a cobalt-chromium substrate, an outer chromium nitride hardened surface layer substantially free of surface roughness, and a hardened diffusion layer underneath the outer surface layer. The hardened diffusion layer comprises a solid solution of nitrogen, oxygen, and carbon and is thicker than the outer layer. The implant is prepared by hardening the surface of the cobalt-chromium substrate by exposing the substrate to an atmosphere of substantially non-diluted molecular nitrogen gas or ionized nitrogen at a process temperature within the range of 500° F. to 2400° F. for a process time duration sufficient to achieve the hardened diffusion layer and the hardened outer surface layer. The process results in enhanced wear properties by substantially avoiding increased surface roughness.
The invention further provides, in one form thereof, a method of manufacturing a cobalt-chromium orthopedic implant device having enhanced wear resistance properties. The method includes an initial step of providing a cobalt-chromium substrate in the form of an orthopedic implant device, or component thereof. A surface hardening step is then performed. Specifically, the surface of the cobalt-chromium substrate is hardened by exposing the substrate to an atmosphere of substantially non-diluted molecular nitrogen gas or ionized nitrogen at a process temperature within the range of 500° F. to 2400° F. for a process time duration sufficient to achieve a hardened diffusion layer and a hardened outer surface layer. The surface of the cobalt-chromium substrate is then mechanically polished to get a highly polished smooth surface. The polishing is carried out in such a way that a minimum amount of metal is removed from the surface. In one aspect of the invention, the process temperature is approximately 1400° F., and the process time duration is approximately forty-eight hours.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a side view of a femoral component for a hip prosthesis, representing a cobalt-chromium-molybdenum orthopedic implant device of the type to which the surface hardening process of the present invention is applicable;
FIG. 2 is a diagrammatic representation of the process steps involved in an exemplary embodiment of the method of the present invention; and
FIG. 3 is a graph diagram showing the qualitative relationship between process temperature and time, and properties of a cobalt-chromium orthopedic implant device subjected to the surface hardening process of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
Referring now to FIG. 1, there is shown an orthopedic implant device 10 fabricated from a cobalt-chromium alloy material and treated in accordance with the surface hardening method of the present invention. The term "cobalt-chromium material" as used herein is intended to encompass both cobalt-chromium based alloys and cobalt-chromium-molybdenum alloys, in particular. Two such cobalt-chromium-molybdenum alloys commonly used in orthopedic applications because of their strength, corrosion resistance, and biocompatability are ASTM F-75 and ASTM F-799. Commercial examples of ASTM F-75 alloys include The Hayes Stellite 21 the Haynes Stellite 6B (TM) alloy and the Ultimet (TM) alloy. In addition, an ASTM F-75 alloy is available having a high carbon and nitrogen content, and is known as Modified ASTM F-75 alloy.
In the disclosed embodiment of the present invention, orthopedic implant device 10 comprises a femoral component for a hip prosthesis of the type disclosed in U.S. Pat. No. 4,813,963, assigned to the same assignee as the present invention, the disclosure of which is hereby incorporated by reference. Generally, femoral component 10 includes a distal end 12, and a proximal end 14 having a neck 16 adapted to carry a ball 18 shown in phantom in FIG. 1. Femoral component 10 is intended to fit within an intramedullary canal of the femur (not shown) such that proximal end 14 extends outwardly from the intramedullary canal of the femur to cooperate with an acetabulum by means of ball 18. Femoral component 10 includes a plurality of longitudinally extending grooves 20 at distal end 12 and a porous surface 22 encircling the femoral component at an intermediate location along femoral component 10.
Referring now to FIG. 2, the steps for hardening the orthopedic implant device in accord with an exemplary embodiment of the present invention are diagrammatically illustrated. Generally, block 30 represents the first step of providing at least one cobalt-chromium orthopedic implant device or component part thereof. As previously discussed, ASTM F-75 or ASTM F-799 alloys are used for the implant device in the disclosed embodiment of the invention. Block 32 represents the next step of cleaning the device to remove all residues. Specifically, after an initial cleaning, the orthopedic implant devices are handled with gloved hands. The devices are then ultrasonically cleaned for 30 minutes in isopropyl alcohol and are then spray-dried to obtain a spot-free clean surface.
The next step of the process, represented by block 36 is placing the implant devices in a furnace. The furnace of the preferred embodiment is a vacuum furnace manufactured by Vacuum Furnace Systems (VFS) Corporation of Souderton, Pa. It is recommended that any furnace used for surface hardening the disclosed cobalt-chromium orthopedic implant devices be capable of maintaining a pressure level of 1×10-6 Torr, a leak rate not exceeding 5 microns per hour, and a thermal uniformity of ±25° F. in vacuum and within ±50° F. in a nitrogen gas atmosphere, at operating temperatures.
As part of the step of placing the implant devices in the furnace, a furnace load is prepared, consisting of properly cleaned orthopedic implant devices assembled on suitable fixtures. The implant devices may or may not include any preattached bone ingrowth features, assembled on suitable fixtures. When placed in the furnace, the boundaries of the load must not extend beyond the uniform hot zone of the furnace. The number of parts in a load is dependent upon component size and fixture geometry. If desired, a predetermined mass of compacted titanium wire is equally divided and placed within and around the load to act as a getter. Cobalt-chromium alloy surface hardening can also be conducted without the getter material. Only materials which do not contaminate the cobalt-chromium alloy may be placed in the furnace with the load. Examples include outgassed high purity graphite, high purity alumina, zirconia, molybdenum, tantalum, and titanium.
After the load is placed in the furnace chamber, the next step is pumping down (evacuating) the chamber to 1×10-5 Torr pressure and then backfilling with high purity nitrogen gas or ionized nitrogen to one atmosphere (or 0 psig), i.e., substantially non-diluted as represented by block 36. For purposes of this application, the term "non-diluted gas" shall include a non-rarefied gas. The step of block 36 is preferably performed at least twice, in order to remove any impurities. The chamber is then purged by once again pumping down or evacuating to 1×10-5 Torr pressure, as represented by block 38. The minimum purity of molecular nitrogen gas used in the disclosed embodiment of the present invention is preferably 99.998 percent, with maximum allowable impurities of 10 ppm oxygen and 4 ppm water (vapor). In addition to these allowable impurities, the nitrogen gas may contain a trace of argon. The gas should also have a -90° F. dew point.
The next step, as represented by block 40 in FIG. 2, is heating the furnace at a rate of 25° F. per minute to a temperature of 1300° F.±50° F. and holding that temperature for 30 minutes to accomplish an equilibrating soak. The next step, represented by block 44, is filling the furnace with non-diluted nitrogen gas or ionized nitrogen to a pressure greater than one atmosphere pressure. A preferred range for the attained pressure is a minimum of 1 psig and a maximum of 2 psig; however, process pressure may be varied further without departing from spirit or scope of the invention. Block 46 of FIG. 2 represents the next step of heating the furnace at 20° F. per minute to a process temperature of 1400° F.±50° F. In the next step of the process, as described in block 48, an equilibrating soak is performed for 30 minutes at the process temperature.
According to the next step of the process, represented by block 50, the implant devices are processed for a predetermined process time duration at the process temperature. Specifically, a surface hardening cycle is run at the process temperature for various time periods depending upon the hardness and thickness of the hardened layer desired from the process. Preferably, the time period ranges from 8 to 48 hours. The hardening cycle is not considered to begin until any and all monitoring thermocouples are within the specified range for the process temperature.
Upon completion of the surface hardening cycle, the load may either be nitrogen quenched or furnace cooled, as the implant devices are cooled down, according to the step of block 52. The furnace is not opened until the temperature of the load is stabilized at 200° F.±25° F., or less, as measured by the highest reading monitoring thermocouple. The furnace may then be opened and the load removed, after which final passivation and processing is performed according to the steps of blocks 54 and 56, respectively. The final passivation step may also include polishing as shown in block 58.
While a specific combination of process temperature and time have been specified, it is appreciated that the cobalt-chromium alloy surface hardening method of the present invention can also be conducted at different temperatures in the range of 500° F. to 2400° F. at different nitrogen gas pressures, and for different time periods to produce the characteristic results of the present invention. This is graphically illustrated by the graph diagram of FIG. 3 showing the qualitative relationship between process temperature and time and the properties of cobalt-chromium orthopedic implant devices subjected to the surface hardening process of the present invention.
Referring to FIG. 3, it can be seen that surface hardness and wear resistance of the cobalt-chromium alloy increases with increasing processing temperature within the range of 500° F. to 2400° F. in accordance with the surface hardening process of the present invention. However, beyond this temperature range, the formation of a measurable nitride layer on the surface increases surface roughness and brittleness as previously described, causing wear resistance to diminish. Fatigue strength and corrosion resistance generally remain constant within this temperature range. Similarly, the aforementioned changes in the properties are generally observed as process time is varied for a given process temperature within the specified temperature range.
In order to monitor the process, witness coupons of the same alloy and condition as the items in the load are placed in the furnace to assess the outcome of the process. One coupon is placed as closely as possible to the center of the load. The remaining coupons are placed in the hottest and coldest spots in the load as defined by previous survey. After the completion of the surface hardening cycle, the microhardness of the treated coupons is measured with a 2 gram load using a Knoop indentor. The surface hardening process of the present invention has been found to significantly increase the surface hardness of the cobalt-chromium material from its untreated condition. The hardness can be increased up to 5000 KHN depending upon the temperature, time, and nitrogen gas pressure used in the process. For instance, the average 2 gram Knoop surface hardness of the cobalt-chromium alloy processed at a process temperature of 1400° F. for a process time of 48 hours is approximately 1000 KHN, while the 2 gram Knoop surface hardness of the untreated alloy is in the range of 300-600 KHN.
Nitrogen depth profiles are also performed on the coupons to measure the depth concentration of nitrogen and oxygen, as by Electron Spectroscopy for Chemical Analysis (ESCA). The peak nitrogen concentration falls within the range of 5 atomic percent to 50 atomic percent and occurs at a depth between 100 and 1000 Angstroms from the alloy surface. An example of such a profile is exhibited in Tables I and II for a cobalt-chromium-molybdenum alloy, specifically ASTM F-75, for depths up to 2000 Angstroms (Table I) and 5000 Angstroms (Table II) below the surface of the alloy.
              TABLE I                                                     
______________________________________                                    
Depth in                                                                  
Angstroms      Composition in Atomic Percent                              
Cycle (SiO.sub.2 Equivalent)                                              
                   Mo     C    N    O    Cr   Co                          
______________________________________                                    
1     --           --     48.0 9.2  41.0 1.8  --                          
2      100         1.3    13.0 12.0 46.0 21.0 6.8                         
3      200         2.7    10.0 15.0 30.0 29.0 13.0                        
4      300         4.3    5.0  16.0 22.0 34.0 18.0                        
5      400         4.9    4.5  17.0 17.0 36.0 21.0                        
6      500         4.9    4.6  17.0 14.0 36.0 23.0                        
7      600         5.5    4.4  16.0 12.0 36.0 25.0                        
8      700         6.4    3.2  16.0 13.0 37.0 25.0                        
9      800         5.6    2.5  15.0 12.0 38.0 28.0                        
10     900         6.8    .8   15.0 9.4  38.0 30.0                        
11    1000         6.9    3.2  14.0 8.6  36.0 31.0                        
12    1100         7.2    2.2  13.0 7.4  37.0 33.0                        
13    1200         7.8    3.3  14.0 6.6  35.0 34.0                        
14    1300         8.0    2.5  14.0 5.6  35.0 35.0                        
15    1400         8.3    1.4  13.0 5.2  34.0 38.0                        
16    1500         8.1    2.1  12.0 4.5  33.0 40.0                        
17    1600         7.6    1.3  13.0 5.0  34.0 39.0                        
18    1700         8.4    2.3  10.0 3.3  35.0 41.0                        
19    1800         8.8    2.0  11.0 2.4  35.0 41.0                        
20    1900         8.5    1.6  10.0 2.6  33.0 44.0                        
21    2000         7.9    2.0  11.0 2.4  33.0 43.0                        
______________________________________                                    
              TABLE II                                                    
______________________________________                                    
Depth In                                                                  
Angstroms      Composition in Atomic Percent                              
Cycle (SiO.sub.2 Equivalent)                                              
                   Mo     C    N    O    Cr   Co                          
______________________________________                                    
1       0          --     49.0 8.7  40.0  2.2 --                          
2     1000         6.9    5.6  14.0  7.2 37.0 30.0                        
3     2000         9.7    1.8  9.8   2.2 32.0 45.0                        
4     3000         9.5    2.2  7.6  --   33.0 48.0                        
5     4000         9.5    1.8  8.4  --   34.0 46.0                        
6     5000         9.0    1.5  8.7  --   34.0 47.0                        
______________________________________                                    
The fatigue strength of the cobalt-chromium alloy subjected to the process of the present invention was quantitatively tested by measuring the bending fatigue strength in units of kilopounds/in2. It was determined that the disclosed low temperature surface hardening process results in minimal or no loss of fatigue properties.
The wear resistance of the cobalt-chromium alloy surface hardened in accordance with the disclosed process was tested by performing wear tests on a pin-on-disk wear tester, using ultrahigh molecular weight polyethylene (UHMWPE), bone, and bone cement pins to simulate actual implant conditions. Significant improvement in both sliding and abrasive wear resistance properties were observed.
Concerning the corrosion resistance properties of the cobalt-chromium subjected to the surface hardening process of the present invention, there does not appear to be any compromise of corrosion resistance. In fact, it has been found that surface hardened cobalt-chromium and cobalt-chromium-molybdenum alloys exhibit corrosion resistance as good as untreated cobalt-chromium alloys.
Contact angle measurements, which measure the angle between the surface of a liquid solvent (e.g. water, serum) and the surface of the alloy at the line of contact, were conducted in order to test the lubricity of the outer surface hardened layer of the alloys treated in the manner of the present invention. In the present case, water was the solvent of use. In general, the lower the contact angle, the more wettable the surface, which indicates greater lubricity. In an illustrative example, it has been found that a water droplet contact angle of about 44° is achieved for an alloy treated at 1400° F. for 48 hours. In contrast, the droplet contact angle for untreated alloys is generally about 70°.
In an effort to analyze the nature of the hardened surface produced by the aforementioned method of the present invention, treated samples of polished ASTM F-75 were analyzed through an Electron Spectroscopy for Chemical Analysis (ESCA) to identify phases or species present on the surface and to obtain surface chemistry versus depth plots of the samples including various spectra.
The surface hardening process of the disclosed preferred embodiment, as analyzed by the aforementioned method, produces a hardened surface layer, which is limited in thickness to a depth approximately 100 micrometers. The hardened surface layer is believed to include chromium nitride with different stoichiometries. It is also believed to have chromium oxide with different stoichiometries. The hardened surface layer is also believed to have some carbides in the form of chromium carbide.
Underneath the hardened surface layer is a hardened diffusion region that is hardened due to solid solution hardening of the cobalt-chromium alloy. The solid solution hardening elements in this case are nitrogen, oxygen, and carbon. This region extends several microns from the surface of the device. The ESCA analyses indicate that the hardened surface layer and harder diffusion region together constitute the desired hardened surface. Specifically, metallurgical changes on the surface of the treated cobalt-chromium implant device include the presence of chromium nitride, chromium oxide, chromium carbide, and solid solution of nitrogen in cobalt-chromium-molybdenum alloy, all of which together produce the desired hardening effect.
While the surface hardening process of the present invention is particularly applicable to orthopedic applications involving load bearing prostheses in articulating contact with bone, metals, ceramics or polymers, e.g., hip, knee, ankle, elbow, shoulder, wrist, finger, and toe joints, and may also be used to treat all cobalt-chromium and cobalt-chromium-molybdenum alloy fracture fixation devices as well.
It will be appreciated that the foregoing description of a preferred embodiment of the invention is presented by way of illustration only and not by way of any limitation, and that various alternatives and modifications may be made to the illustrated embodiment without departing from the spirit and scope of the invention.

Claims (21)

What is claimed is:
1. A method of manufacturing a cobalt-chromium orthopedic implant device having enhanced wear resistance properties, comprising the steps of:
providing a cobalt-chromium substrate in the form of an orthopedic implant device; and
hardening the surface of the cobalt-chromium substrate by exposing the cobalt-chromium substrate to an atmosphere of non-diluted molecular nitrogen gas at a process temperature within the range of 500° F. to 2400° F. for a process time duration sufficient to achieve a hardened outer surface layer and a hardened diffusion layer characterized primarily by solid solution hardening of the surface of the cobalt-chromium substrate by dissolution of nitrogen and oxygen in the cobalt-chromium substrate.
2. The method of claim 1 in which the orthopedic implant device is a load bearing member.
3. The method of claim 1 in which the orthopedic implant device makes articulating contact with one of a polymer, a ceramic or a metal.
4. The method of claim 1 in which said hardened surface region exhibits a peak nitrogen concentration within the range of about 5 atomic percent to about 50 atomic percent at a depth between 100 and 5000Å below the surface of the outer substrate.
5. The method of claim 1 in which said hardened surface region includes a hardened surface layer limited in thickness to a depth of approximately 100 micrometers and a hardened diffusion region underneath said hardened surface layer, said surface layer comprising chromium nitride, chromium oxide, and chromium carbide, and said hardened diffusion region comprising a solid solution of nitrogen, oxygen, and carbon in said cobalt-chromium substrate.
6. The method of claim 3 in which the polymer is ultrahigh molecular weight polyethylene (UHMWPE).
7. A method of manufacturing a cobalt-chromium orthopedic implant device having enhanced surface hardness and wear resistance properties, comprising the steps of:
providing a cobalt-chromium substrate in the form of an orthopedic implant device; and
exposing the cobalt-chromium substrate to an atmosphere of molecular nitrogen gas at a process temperature and for a process time duration sufficient to cause nitrogen dissolution in the cobalt-chromium substrate without a substantial quantity of formation of a substantial quantity of chromium nitride on the surface of said the cobalt-chromium substrate, thereby enhancing the surface hardness and wear resistance properties of the cobalt-chromium substrate by substantially avoiding increased surface roughness and brittleness that would diminish the wear resistance properties.
8. The method of claim 7 in which said cobalt-chromium substrate comprises a cobalt-chromium-molybdenum alloy.
9. The method of claim 7 in which said cobalt-chromium alloy is one of ASTM F-75 and Modified ASTM F-75.
10. The method of claim 7 in which the process temperature is in the range of 500° F. to 2400° F.
11. The method of claim 7 in which the process time is approximately forty-eight hours.
12. The method of claim 7 in which the process temperature is approximately 1400° F. and the process time is approximately forty-eight hours.
13. The method of claim 7 in which said atmosphere of molecular nitrogen gas is provided at a process pressure within the range of 1 psig to 2 psig.
14. The method of claim 9 in which the cobalt-chromium alloy is ASTM F-799.
15. The method of claim 10 in which the process temperature is approximately 1400° F.
16. A method of increasing the surface hardness and wear resistance properties of an orthopedic implant device that is fabricated from a cobalt-chromium material, comprising the steps of:
providing a substrate of cobalt-chromium material in the form of an orthopedic implant device; and
exposing the substrate to an atmosphere of non-diluted molecular nitrogen gas at a process temperature and for a process time duration sufficient to enhance both surface hardness and wear resistance properties of said substrate by nitrogen dissolution in the substrate by substantially avoiding increased surface roughness and brittleness and thereby diminishing wear resistance properties by the formation of a substantial quantity of chromium nitride on the surface of the substrate.
17. The method of claim 16 including the step of polishing the surface hardened implant device sufficiently to provide an ultrahigh finish to the device, thereby substantially improving the wear resistance of the implant.
18. The method of claim 16 in which the process temperature is in the range of 500° F. to 2400° F.
19. A method of manufacturing a cobalt-chromium orthopedic implant device having enhanced wear resistance properties, comprising the steps of:
providing a cobalt-chromium substrate in the form of an orthopedic implant device; and
hardening the surface of the cobalt-chromium substrate by exposing the cobalt-chromium substrate to an atmosphere of ionized nitrogen at a process temperature within the range of 500° F. to 2400° F. for a process time duration sufficient to achieve a hardened outer surface layer and a hardened diffusion layer characterized primarily by solid solution hardening of the surface of the cobalt-chromium substrate by dissolution of nitrogen and oxygen in the cobalt-chromium substrate.
20. A method of manufacturing a cobalt-chromium orthopedic implant device having enhanced surface hardness and wear resistance properties, comprising the steps of:
providing a cobalt-chromium substrate in the form of an orthopedic implant device; and
exposing the cobalt-chromium substrate to an atmosphere of ionized nitrogen at a process temperature and for a process time duration sufficient to cause nitrogen dissolution in the cobalt-chromium substrate without formation of a substantial quantity of chromium nitride on the surface of said the cobalt-chromium substrate, thereby enhancing the surface hardness and wear resistance properties of the cobalt-chromium substrate by substantially avoiding increased surface roughness and brittleness that would diminish the wear resistance properties.
21. A method of increasing the surface hardness and wear resistance properties of an orthopedic implant device that is fabricated from a cobalt-chromium material, comprising the steps of:
providing a substrate of cobalt-chromium material in the form of an orthopedic implant device; and
exposing the substrate to an atmosphere of ionized nitrogen at a process temperature and for a process time duration sufficient to enhance both surface hardness and wear resistance properties of said substrate by nitrogen dissolution in the substrate by substantially avoiding increased surface roughness and brittleness and thereby diminishing wear resistance properties by the formation of a substantial quantity of chromium nitride on the surface of the substrate.
US08/030,912 1993-03-15 1993-03-15 Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices Expired - Lifetime US5308412A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US08/030,912 US5308412A (en) 1993-03-15 1993-03-15 Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/030,912 US5308412A (en) 1993-03-15 1993-03-15 Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices

Publications (1)

Publication Number Publication Date
US5308412A true US5308412A (en) 1994-05-03

Family

ID=21856659

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/030,912 Expired - Lifetime US5308412A (en) 1993-03-15 1993-03-15 Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices

Country Status (1)

Country Link
US (1) US5308412A (en)

Cited By (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415704A (en) * 1992-02-07 1995-05-16 Smith & Nephew Richards Inc. Surface hardened biocompatible metallic medical implants
EP0747025A1 (en) * 1995-06-07 1996-12-11 SMITH & NEPHEW RICHARDS, INC. Low wear artificial spinal disc
US5593447A (en) * 1995-08-25 1997-01-14 Angeli; Jose A. Minimal contact prosthesis
US5702456A (en) * 1994-07-19 1997-12-30 The University Of Kentucky Research Foundation Implant having reduced generation of wear particulates
FR2751526A1 (en) * 1996-07-29 1998-01-30 Claude Hubin JOINT PART OF A HIP PROSTHESIS WITH PARTICLE TRAP
US5716414A (en) * 1994-04-28 1998-02-10 Johnson & Johnson Professional, Inc. Ceramic/metallic articulation component and prothesis
EP0841041A2 (en) * 1996-11-12 1998-05-13 Johnson & Johnson Medical Ltd. Hip joint prosthesis
US5891191A (en) * 1996-04-30 1999-04-06 Schneider (Usa) Inc Cobalt-chromium-molybdenum alloy stent and stent-graft
WO2000047140A1 (en) * 1999-02-10 2000-08-17 Ati Properties, Inc. Enhanced biocompatible implants and alloys
EP1035230A1 (en) 1999-03-12 2000-09-13 Bristol-Myers Squibb Company Enhanced fatigue strength orthopaedic implant with porous coating and method of making same
US6398815B1 (en) 2000-01-30 2002-06-04 Diamicron, Inc. Prosthetic joint having at least one superhard articulation surface
US6410877B1 (en) 2000-01-30 2002-06-25 Diamicron, Inc. Methods for shaping and finishing prosthetic joint components including polycrystalline diamond compacts
US6417292B1 (en) 2000-04-07 2002-07-09 Ppg Industries Ohio, Inc. Electrodepositable coating compositions including ungelled reaction products of epoxy functional polyesters and amines coated substrates and methods of electrocoating using the same
US6425922B1 (en) 2000-01-30 2002-07-30 Diamicron, Inc. Prosthetic hip joint having at least one sintered polycrystalline diamond compact articulation surface
EP1234556A2 (en) * 2001-02-23 2002-08-28 Zimmer Inc. Femoral stem with strengthening rib
US6488715B1 (en) 2000-01-30 2002-12-03 Diamicron, Inc. Diamond-surfaced cup for use in a prosthetic joint
US6494918B1 (en) 2000-01-30 2002-12-17 Diamicron, Inc. Component for a prosthetic joint having a diamond load bearing and articulation surface
WO2003003950A1 (en) * 2001-07-06 2003-01-16 Depuy International Limited An orthopaedic joint prosthesis
US20030019106A1 (en) * 2001-04-22 2003-01-30 Diamicron, Inc. Methods for making bearings, races and components thereof having diamond and other superhard surfaces
US6514289B1 (en) 2000-01-30 2003-02-04 Diamicron, Inc. Diamond articulation surface for use in a prosthetic joint
US20030119069A1 (en) * 1999-04-20 2003-06-26 Target Discovery, Inc. Labeling of protein samples
US6596225B1 (en) 2000-01-31 2003-07-22 Diamicron, Inc. Methods for manufacturing a diamond prosthetic joint component
WO2003093527A1 (en) * 2002-04-29 2003-11-13 Ad.Surf.Eng. Surface treatment of co-cr based alloys using plasma carburization
US6676704B1 (en) 1994-08-12 2004-01-13 Diamicron, Inc. Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US6709463B1 (en) 2000-01-30 2004-03-23 Diamicron, Inc. Prosthetic joint component having at least one solid polycrystalline diamond component
US20040148033A1 (en) * 2003-01-24 2004-07-29 Schroeder David Wayne Wear surface for metal-on-metal articulation
EP1442726A1 (en) * 2003-01-31 2004-08-04 Howmedica Osteonics Corp. Meniscal and tibial implants
US6793681B1 (en) 1994-08-12 2004-09-21 Diamicron, Inc. Prosthetic hip joint having a polycrystalline diamond articulation surface and a plurality of substrate layers
US20040199260A1 (en) * 2000-01-30 2004-10-07 Pope Bill J. Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US20040213891A1 (en) * 2003-09-02 2004-10-28 Ronghua Wei Method and apparatus for forming a nitride layer on a biomedical device
US20040236433A1 (en) * 2003-05-23 2004-11-25 Kennedy Richard L. Cobalt alloys, methods of making cobalt alloys, and implants and articles of manufacture made therefrom
US20050031663A1 (en) * 1997-05-16 2005-02-10 Cecilia Larsson Implant element
US20050087915A1 (en) * 1999-12-08 2005-04-28 Diamicron, Inc. Carbides as a substrate material in prosthetic joints
US20050110187A1 (en) * 1999-12-08 2005-05-26 Diamicron, Inc. Use of Ti and Nb cemented in TiC in prosthetic joints
US20050133277A1 (en) * 2003-08-28 2005-06-23 Diamicron, Inc. Superhard mill cutters and related methods
US6911100B1 (en) 2002-08-30 2005-06-28 Biomet, Inc. Method for controlling residual stress in prosthetics
US20050149188A1 (en) * 2002-02-07 2005-07-07 Cook Stephen D. Anterior spinal implant
US20050154458A1 (en) * 2003-09-22 2005-07-14 Howmedica International S. De R.L. Apparatus for the regeneration of human tissue
US20050155679A1 (en) * 2003-04-09 2005-07-21 Coastcast Corporation CoCr alloys and methods for making same
US20050164041A1 (en) * 2004-01-23 2005-07-28 Dunsmore David V. Medical device having a smooth, hardened surface
US20050197703A1 (en) * 2004-03-03 2005-09-08 Diaz Robert L. Spinal implant
US20050203630A1 (en) * 2000-01-30 2005-09-15 Pope Bill J. Prosthetic knee joint having at least one diamond articulation surface
US20050203633A1 (en) * 2004-03-02 2005-09-15 Alfred Fernandes Lifetime solution for hip dysfunction
US20050242162A1 (en) * 2002-06-18 2005-11-03 Medlin Dana J Method for attaching a porous metal layer to a metal substrate
US20060074491A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Boronized medical implants and process for producing the same
US20060085077A1 (en) * 2004-10-18 2006-04-20 Ebi, L.P. Intervertebral implant and associated method
US7115144B2 (en) 2004-03-02 2006-10-03 Joint Synergy, Llc Spinal implant
US20060263233A1 (en) * 1999-12-08 2006-11-23 Diamicron, Inc. Use of a metal and Sn as a solvent material for the bulk crystallization and sintering of diamond to produce biocompatbile biomedical devices
US7195644B2 (en) 2004-03-02 2007-03-27 Joint Synergy, Llc Ball and dual socket joint
US20080027431A1 (en) * 2006-07-29 2008-01-31 Williams James M Coated medical device and method of making
US7338529B1 (en) 2004-03-30 2008-03-04 Biomet Manufacturing Corp. Methods and apparatuses for enhancing prosthetic implant durability
US20080071381A1 (en) * 2004-07-16 2008-03-20 Robin Buscher Implant
US7361192B2 (en) 2005-04-22 2008-04-22 Doty Keith L Spinal disc prosthesis and methods of use
US20080140212A1 (en) * 2001-05-15 2008-06-12 Robert Metzger Elongated femoral component
US20080154380A1 (en) * 2000-01-30 2008-06-26 Dixon Richard H Articulating diamond-surfaced spinal implants
US7396505B2 (en) * 1994-08-12 2008-07-08 Diamicron, Inc. Use of CoCrMo to augment biocompatibility in polycrystalline diamond compacts
US20080269908A1 (en) * 2007-04-27 2008-10-30 Piper Medical, Inc. Carpometacarpal (cmc) joint arthoplasty implants and related jigs, medical kits and methods
US20090012624A1 (en) * 2005-09-30 2009-01-08 Depuy Products, Inc. Aluminum oxide coated implants and components
US7491239B2 (en) 2005-02-23 2009-02-17 Joint Synergy, Llc Interior insert ball and dual socket joint
US20090046967A1 (en) * 2001-04-22 2009-02-19 Pope Bill J Bearings, races and components thereof having diamond and other superhard surfaces
US20090164012A1 (en) * 2007-12-21 2009-06-25 Howmedica Osteonics Corp. Medical implant component and method for fabricating same
US20090198343A1 (en) * 2008-01-31 2009-08-06 Tecvac Ltd. Coated articles
US20090263643A1 (en) * 2005-04-07 2009-10-22 Gardinier Clayton F Use of sn and pore size control to improve biocompatibility in polycrystalline diamond compacts
US20100016987A1 (en) * 2008-07-16 2010-01-21 Zimmer, Inc. Thermally treated ceramic coating for implants
US20100025898A1 (en) * 2000-01-30 2010-02-04 Pope Bill J USE OF Ti AND Nb CEMENTED TiC IN PROSTHETIC JOINTS
US20100051141A1 (en) * 2008-09-02 2010-03-04 Zimmer, Inc. Method for enhancing fretting fatigue resistance of alloys
EP2204198A1 (en) * 2008-12-30 2010-07-07 Sandvik Intellectual Property AB Designed surfaces for use in medical implants or instruments
US20100198353A1 (en) * 2000-01-30 2010-08-05 Pope Bill J USE OF Ti and Nb CEMENTED IN TiC IN PROSTHETIC JOINTS
US7780676B2 (en) 2006-07-11 2010-08-24 Ebi, Llc Intervertebral implantation apparatus
US20110004794A1 (en) * 2009-07-03 2011-01-06 Jeong-Hun Lee Semiconductor memory device
US20110033309A1 (en) * 2009-08-07 2011-02-10 Chia-Teh Chen Ceiling fan positioning structure for shielding a hanging portion of a ceiling fan
US20110146348A1 (en) * 2009-06-26 2011-06-23 Harding David P Thick sintered polycrystalline diamond and sintered jewelry
US8277505B1 (en) 2011-06-10 2012-10-02 Doty Keith L Devices for providing up to six-degrees of motion having kinematically-linked components and methods of use
US8721722B2 (en) 2004-10-18 2014-05-13 Ebi, Llc Intervertebral implant and associated method
US20150069111A1 (en) * 2012-06-18 2015-03-12 DePuy Synthes Products, LLC Dual modulus hip stem and method of making the same
US8985430B2 (en) 2002-06-18 2015-03-24 Zimmer, Inc. Method for attaching a porous metal layer to a metal substrate
US9775713B2 (en) 2006-01-18 2017-10-03 Smith & Nephew, Inc. Applications of diffusion hardening techniques
US10070959B2 (en) 2016-09-28 2018-09-11 DePuy Synthes Products, Inc. Method of texturing prosthetic implants
US10828168B2 (en) 2017-05-10 2020-11-10 Howmedica Osteonics Corp. Patient specific composite knee replacement
CN114831780A (en) * 2022-03-25 2022-08-02 四川大学华西医院 Cobalt alloy bone trabecula femur condyle prosthesis containing nitride layer and preparation method thereof
CN115161516A (en) * 2022-07-18 2022-10-11 嘉兴数字三维智能制造研究院有限公司 Cobalt-chromium alloy powder material special for dentistry

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3713175A (en) * 1970-11-19 1973-01-30 Howmedica Metal alloy cardiovascular implant device
US4668290A (en) * 1985-08-13 1987-05-26 Pfizer Hospital Products Group Inc. Dispersion strengthened cobalt-chromium-molybdenum alloy produced by gas atomization
US4714468A (en) * 1985-08-13 1987-12-22 Pfizer Hospital Products Group Inc. Prosthesis formed from dispersion strengthened cobalt-chromium-molybdenum alloy produced by gas atomization
US4743308A (en) * 1987-01-20 1988-05-10 Spire Corporation Corrosion inhibition of metal alloys
US5152794A (en) * 1989-07-25 1992-10-06 Smith & Nephew Richards Inc. Zirconium oxide and nitride coated prothesis for reduced microfretting
US5152795A (en) * 1990-04-25 1992-10-06 Spire Corporation Surgical implants and method
US5171275A (en) * 1990-02-15 1992-12-15 Ling Robin S M Femoral stem prosthesis
US5192323A (en) * 1990-11-05 1993-03-09 Zimmer, Inc. Method of surface hardening orthopedic implant devices
US5198308A (en) * 1990-12-21 1993-03-30 Zimmer, Inc. Titanium porous surface bonded to a cobalt-based alloy substrate in an orthopaedic implant device

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3713175A (en) * 1970-11-19 1973-01-30 Howmedica Metal alloy cardiovascular implant device
US4668290A (en) * 1985-08-13 1987-05-26 Pfizer Hospital Products Group Inc. Dispersion strengthened cobalt-chromium-molybdenum alloy produced by gas atomization
US4714468A (en) * 1985-08-13 1987-12-22 Pfizer Hospital Products Group Inc. Prosthesis formed from dispersion strengthened cobalt-chromium-molybdenum alloy produced by gas atomization
US4743308A (en) * 1987-01-20 1988-05-10 Spire Corporation Corrosion inhibition of metal alloys
US5152794A (en) * 1989-07-25 1992-10-06 Smith & Nephew Richards Inc. Zirconium oxide and nitride coated prothesis for reduced microfretting
US5171275A (en) * 1990-02-15 1992-12-15 Ling Robin S M Femoral stem prosthesis
US5152795A (en) * 1990-04-25 1992-10-06 Spire Corporation Surgical implants and method
US5192323A (en) * 1990-11-05 1993-03-09 Zimmer, Inc. Method of surface hardening orthopedic implant devices
US5198308A (en) * 1990-12-21 1993-03-30 Zimmer, Inc. Titanium porous surface bonded to a cobalt-based alloy substrate in an orthopaedic implant device

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
C. D. Peterson, B. M. Hillberry, and D. A. Heck, "Component Wear of Total Knee Prostheses Using Ti-6A1-4V, Titanium Nitride Coated Ti-6A1-4V, and Cobalt-Chromium-Molybdenum Femoral Components," Journal of Biomedical Materials Research, vol. 22, 887-903 (1988).
C. D. Peterson, B. M. Hillberry, and D. A. Heck, Component Wear of Total Knee Prostheses Using Ti 6A1 4V, Titanium Nitride Coated Ti 6A1 4V, and Cobalt Chromium Molybdenum Femoral Components, Journal of Biomedical Materials Research, vol. 22, 887 903 (1988). *
Grill, A. Raven and R. Anvi, "Layer Structure and Mechanical Properties of Low Pressure" R. F. Plasma and Nitrided Ti-6A1-4V Alloy Surface and Coatings Technology 43/44 (1990) 745-755.
Grill, A. Raven and R. Anvi, Layer Structure and Mechanical Properties of Low Pressure R. F. Plasma and Nitrided Ti 6A1 4V Alloy Surface and Coatings Technology 43/44 (1990) 745 755. *
Guillermet et al. Z. Metallkoe 83 (Jan. 1992) 21. *
Wisbey et al. Biomaterials vol. 8 (1987) 477. *

Cited By (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415704A (en) * 1992-02-07 1995-05-16 Smith & Nephew Richards Inc. Surface hardened biocompatible metallic medical implants
US5676701A (en) * 1993-01-14 1997-10-14 Smith & Nephew, Inc. Low wear artificial spinal disc
US5716414A (en) * 1994-04-28 1998-02-10 Johnson & Johnson Professional, Inc. Ceramic/metallic articulation component and prothesis
US6105235A (en) * 1994-04-28 2000-08-22 Johnson & Johnson Professional, Inc. Ceramic/metallic articulation component and prosthesis
US5702456A (en) * 1994-07-19 1997-12-30 The University Of Kentucky Research Foundation Implant having reduced generation of wear particulates
US6793681B1 (en) 1994-08-12 2004-09-21 Diamicron, Inc. Prosthetic hip joint having a polycrystalline diamond articulation surface and a plurality of substrate layers
US7396505B2 (en) * 1994-08-12 2008-07-08 Diamicron, Inc. Use of CoCrMo to augment biocompatibility in polycrystalline diamond compacts
US6676704B1 (en) 1994-08-12 2004-01-13 Diamicron, Inc. Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US6800095B1 (en) 1994-08-12 2004-10-05 Diamicron, Inc. Diamond-surfaced femoral head for use in a prosthetic joint
EP0747025A1 (en) * 1995-06-07 1996-12-11 SMITH & NEPHEW RICHARDS, INC. Low wear artificial spinal disc
US5593447A (en) * 1995-08-25 1997-01-14 Angeli; Jose A. Minimal contact prosthesis
US5891191A (en) * 1996-04-30 1999-04-06 Schneider (Usa) Inc Cobalt-chromium-molybdenum alloy stent and stent-graft
AU726102B2 (en) * 1996-04-30 2000-11-02 Schneider (Usa) Inc. Cobalt-chromium-molybdenum alloy stent and stent-graft
FR2751526A1 (en) * 1996-07-29 1998-01-30 Claude Hubin JOINT PART OF A HIP PROSTHESIS WITH PARTICLE TRAP
EP0821922A1 (en) * 1996-07-29 1998-02-04 Claude Hubin Hip prosthesis joint component with particulate trap
EP0841041A2 (en) * 1996-11-12 1998-05-13 Johnson & Johnson Medical Ltd. Hip joint prosthesis
EP0841041A3 (en) * 1996-11-12 1999-03-17 Johnson & Johnson Medical Ltd. Hip joint prosthesis
US20050031663A1 (en) * 1997-05-16 2005-02-10 Cecilia Larsson Implant element
US6187045B1 (en) * 1999-02-10 2001-02-13 Thomas K. Fehring Enhanced biocompatible implants and alloys
US6539607B1 (en) 1999-02-10 2003-04-01 University Of North Carolina At Charlotte Enhanced biocompatible implants and alloys
US6773520B1 (en) 1999-02-10 2004-08-10 University Of North Carolina At Charlotte Enhanced biocompatible implants and alloys
WO2000047140A1 (en) * 1999-02-10 2000-08-17 Ati Properties, Inc. Enhanced biocompatible implants and alloys
US6395327B1 (en) * 1999-03-12 2002-05-28 Zimmer, Inc. Enhanced fatigue strength orthopaedic implant with porous coating and method of making same
JP2000288002A (en) * 1999-03-12 2000-10-17 Bristol Myers Squibb Co Fatigue strength intensifying orthopedic implant having porous coating and its production
US20020127328A1 (en) * 1999-03-12 2002-09-12 H. Ravindranath Shetty Enhanced fatigue strength orthopaedic implant with porous coating and method of making same
US20040133283A1 (en) * 1999-03-12 2004-07-08 Shetty H. Ravindranath Enhanced fatigue strength orthopaedic implant with porous coating and method of making same
US6685987B2 (en) 1999-03-12 2004-02-03 Zimmer Technology, Inc. Enhanced fatigue strength orthopaedic implant with porous coating and method of making same
EP1035230A1 (en) 1999-03-12 2000-09-13 Bristol-Myers Squibb Company Enhanced fatigue strength orthopaedic implant with porous coating and method of making same
US20030119069A1 (en) * 1999-04-20 2003-06-26 Target Discovery, Inc. Labeling of protein samples
US7678325B2 (en) 1999-12-08 2010-03-16 Diamicron, Inc. Use of a metal and Sn as a solvent material for the bulk crystallization and sintering of diamond to produce biocompatbile biomedical devices
US7569176B2 (en) 1999-12-08 2009-08-04 Diamicron, Inc. Method for making a sintered superhard prosthetic joint component
US20050110187A1 (en) * 1999-12-08 2005-05-26 Diamicron, Inc. Use of Ti and Nb cemented in TiC in prosthetic joints
US20050087915A1 (en) * 1999-12-08 2005-04-28 Diamicron, Inc. Carbides as a substrate material in prosthetic joints
US20060263233A1 (en) * 1999-12-08 2006-11-23 Diamicron, Inc. Use of a metal and Sn as a solvent material for the bulk crystallization and sintering of diamond to produce biocompatbile biomedical devices
US7556763B2 (en) 1999-12-08 2009-07-07 Diamicron, Inc. Method of making components for prosthetic joints
US20100198353A1 (en) * 2000-01-30 2010-08-05 Pope Bill J USE OF Ti and Nb CEMENTED IN TiC IN PROSTHETIC JOINTS
US20100025898A1 (en) * 2000-01-30 2010-02-04 Pope Bill J USE OF Ti AND Nb CEMENTED TiC IN PROSTHETIC JOINTS
US6709463B1 (en) 2000-01-30 2004-03-23 Diamicron, Inc. Prosthetic joint component having at least one solid polycrystalline diamond component
US6488715B1 (en) 2000-01-30 2002-12-03 Diamicron, Inc. Diamond-surfaced cup for use in a prosthetic joint
US20050203630A1 (en) * 2000-01-30 2005-09-15 Pope Bill J. Prosthetic knee joint having at least one diamond articulation surface
US6517583B1 (en) 2000-01-30 2003-02-11 Diamicron, Inc. Prosthetic hip joint having a polycrystalline diamond compact articulation surface and a counter bearing surface
US8016889B2 (en) 2000-01-30 2011-09-13 Diamicron, Inc Articulating diamond-surfaced spinal implants
US6494918B1 (en) 2000-01-30 2002-12-17 Diamicron, Inc. Component for a prosthetic joint having a diamond load bearing and articulation surface
US6425922B1 (en) 2000-01-30 2002-07-30 Diamicron, Inc. Prosthetic hip joint having at least one sintered polycrystalline diamond compact articulation surface
US20080154380A1 (en) * 2000-01-30 2008-06-26 Dixon Richard H Articulating diamond-surfaced spinal implants
US20040199260A1 (en) * 2000-01-30 2004-10-07 Pope Bill J. Prosthetic joint component having at least one sintered polycrystalline diamond compact articulation surface and substrate surface topographical features in said polycrystalline diamond compact
US20080215158A1 (en) * 2000-01-30 2008-09-04 Diamicron, Inc. Prosthetic hip joint having polycrystalline diamond articulation surfaces and at least one solid polycrystalline diamond compact
US6410877B1 (en) 2000-01-30 2002-06-25 Diamicron, Inc. Methods for shaping and finishing prosthetic joint components including polycrystalline diamond compacts
US6398815B1 (en) 2000-01-30 2002-06-04 Diamicron, Inc. Prosthetic joint having at least one superhard articulation surface
US8603181B2 (en) 2000-01-30 2013-12-10 Dimicron, Inc Use of Ti and Nb cemented in TiC in prosthetic joints
US6514289B1 (en) 2000-01-30 2003-02-04 Diamicron, Inc. Diamond articulation surface for use in a prosthetic joint
US6596225B1 (en) 2000-01-31 2003-07-22 Diamicron, Inc. Methods for manufacturing a diamond prosthetic joint component
US6417292B1 (en) 2000-04-07 2002-07-09 Ppg Industries Ohio, Inc. Electrodepositable coating compositions including ungelled reaction products of epoxy functional polyesters and amines coated substrates and methods of electrocoating using the same
EP1652496A3 (en) * 2001-02-23 2007-04-25 Zimmer Inc. Femoral stem with strengthening rib
EP1234556A2 (en) * 2001-02-23 2002-08-28 Zimmer Inc. Femoral stem with strengthening rib
EP1234556A3 (en) * 2001-02-23 2004-03-03 Zimmer Inc. Femoral stem with strengthening rib
US20090046967A1 (en) * 2001-04-22 2009-02-19 Pope Bill J Bearings, races and components thereof having diamond and other superhard surfaces
US20030019106A1 (en) * 2001-04-22 2003-01-30 Diamicron, Inc. Methods for making bearings, races and components thereof having diamond and other superhard surfaces
US7665898B2 (en) 2001-04-22 2010-02-23 Diamicron, Inc. Bearings, races and components thereof having diamond and other superhard surfaces
US20080140212A1 (en) * 2001-05-15 2008-06-12 Robert Metzger Elongated femoral component
WO2003003950A1 (en) * 2001-07-06 2003-01-16 Depuy International Limited An orthopaedic joint prosthesis
US20050149188A1 (en) * 2002-02-07 2005-07-07 Cook Stephen D. Anterior spinal implant
AU2003226552B2 (en) * 2002-04-29 2009-03-12 Ad.Surf.Eng. Ltd Surface treatment of Co-Cr based alloys using plasma carburization
WO2003093527A1 (en) * 2002-04-29 2003-11-13 Ad.Surf.Eng. Surface treatment of co-cr based alloys using plasma carburization
US20050241736A1 (en) * 2002-04-29 2005-11-03 Thomas Bell Surface treatment of co-cr based alloys using plasma carburization
US20050242162A1 (en) * 2002-06-18 2005-11-03 Medlin Dana J Method for attaching a porous metal layer to a metal substrate
US9656358B2 (en) 2002-06-18 2017-05-23 Zimmer, Inc. Method for attaching a porous metal layer to a metal substrate
US8985430B2 (en) 2002-06-18 2015-03-24 Zimmer, Inc. Method for attaching a porous metal layer to a metal substrate
US6911100B1 (en) 2002-08-30 2005-06-28 Biomet, Inc. Method for controlling residual stress in prosthetics
US20040148033A1 (en) * 2003-01-24 2004-07-29 Schroeder David Wayne Wear surface for metal-on-metal articulation
US20040153163A1 (en) * 2003-01-31 2004-08-05 Howmedica Osteonics Corp. Meniscal and tibial implants
EP1442726A1 (en) * 2003-01-31 2004-08-04 Howmedica Osteonics Corp. Meniscal and tibial implants
US6994730B2 (en) 2003-01-31 2006-02-07 Howmedica Osteonics Corp. Meniscal and tibial implants
US20050155679A1 (en) * 2003-04-09 2005-07-21 Coastcast Corporation CoCr alloys and methods for making same
US7520947B2 (en) 2003-05-23 2009-04-21 Ati Properties, Inc. Cobalt alloys, methods of making cobalt alloys, and implants and articles of manufacture made therefrom
EP2047871A1 (en) 2003-05-23 2009-04-15 ATI Properties, Inc. Cobalt alloy implant having a hard surface region
US20040236433A1 (en) * 2003-05-23 2004-11-25 Kennedy Richard L. Cobalt alloys, methods of making cobalt alloys, and implants and articles of manufacture made therefrom
US20050133277A1 (en) * 2003-08-28 2005-06-23 Diamicron, Inc. Superhard mill cutters and related methods
US7261914B2 (en) 2003-09-02 2007-08-28 Southwest Research Institute Method and apparatus for forming a nitride layer on a biomedical device
US20040213891A1 (en) * 2003-09-02 2004-10-28 Ronghua Wei Method and apparatus for forming a nitride layer on a biomedical device
US20050154458A1 (en) * 2003-09-22 2005-07-14 Howmedica International S. De R.L. Apparatus for the regeneration of human tissue
WO2005070344A1 (en) * 2004-01-23 2005-08-04 Doncasters Limited A medical device having a smooth, hardened surface
US20050164041A1 (en) * 2004-01-23 2005-07-28 Dunsmore David V. Medical device having a smooth, hardened surface
US20050203633A1 (en) * 2004-03-02 2005-09-15 Alfred Fernandes Lifetime solution for hip dysfunction
US20070162133A1 (en) * 2004-03-02 2007-07-12 Robert Doubler Concentric interior insert ball and dual socket joint
US7195644B2 (en) 2004-03-02 2007-03-27 Joint Synergy, Llc Ball and dual socket joint
US7115144B2 (en) 2004-03-02 2006-10-03 Joint Synergy, Llc Spinal implant
US7083651B2 (en) 2004-03-03 2006-08-01 Joint Synergy, Llc Spinal implant
US20050197703A1 (en) * 2004-03-03 2005-09-08 Diaz Robert L. Spinal implant
US7338529B1 (en) 2004-03-30 2008-03-04 Biomet Manufacturing Corp. Methods and apparatuses for enhancing prosthetic implant durability
US20080071381A1 (en) * 2004-07-16 2008-03-20 Robin Buscher Implant
US20060074491A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Boronized medical implants and process for producing the same
US8721722B2 (en) 2004-10-18 2014-05-13 Ebi, Llc Intervertebral implant and associated method
US20060085077A1 (en) * 2004-10-18 2006-04-20 Ebi, L.P. Intervertebral implant and associated method
US7491239B2 (en) 2005-02-23 2009-02-17 Joint Synergy, Llc Interior insert ball and dual socket joint
US8449991B2 (en) 2005-04-07 2013-05-28 Dimicron, Inc. Use of SN and pore size control to improve biocompatibility in polycrystalline diamond compacts
US9463092B2 (en) 2005-04-07 2016-10-11 Dimicron, Inc. Use of Sn and pore size control to improve biocompatibility in polycrystalline diamond compacts
US20090263643A1 (en) * 2005-04-07 2009-10-22 Gardinier Clayton F Use of sn and pore size control to improve biocompatibility in polycrystalline diamond compacts
US7361192B2 (en) 2005-04-22 2008-04-22 Doty Keith L Spinal disc prosthesis and methods of use
US8309161B2 (en) 2005-09-30 2012-11-13 Depuy Products, Inc. Aluminum oxide coated implants and components
US20090012624A1 (en) * 2005-09-30 2009-01-08 Depuy Products, Inc. Aluminum oxide coated implants and components
US9775713B2 (en) 2006-01-18 2017-10-03 Smith & Nephew, Inc. Applications of diffusion hardening techniques
US11351031B2 (en) 2006-01-18 2022-06-07 Smith & Nephew, Inc. Applications of diffusion hardening techniques
US10512544B2 (en) 2006-01-18 2019-12-24 Smith & Nephew, Inc. Applications of diffusion hardening techniques
US7780676B2 (en) 2006-07-11 2010-08-24 Ebi, Llc Intervertebral implantation apparatus
US20080027431A1 (en) * 2006-07-29 2008-01-31 Williams James M Coated medical device and method of making
US9662220B2 (en) 2007-04-27 2017-05-30 Piper Medical, Inc. Carpometacarpal (CMC) joint arthroplasty implants and related jigs
US8167953B2 (en) 2007-04-27 2012-05-01 Piper Medical, Inc. Carpometacarpal (CMC) joint arthroplasty implants and related jigs, medical kits and methods
US20080269908A1 (en) * 2007-04-27 2008-10-30 Piper Medical, Inc. Carpometacarpal (cmc) joint arthoplasty implants and related jigs, medical kits and methods
US20090164012A1 (en) * 2007-12-21 2009-06-25 Howmedica Osteonics Corp. Medical implant component and method for fabricating same
JP2011510725A (en) * 2008-01-31 2011-04-07 テクバック・リミテッド Coated articles
US8029917B2 (en) 2008-01-31 2011-10-04 Tecvac Ltd. Coated articles
US20090198343A1 (en) * 2008-01-31 2009-08-06 Tecvac Ltd. Coated articles
US8642112B2 (en) 2008-07-16 2014-02-04 Zimmer, Inc. Thermally treated ceramic coating for implants
US20100016987A1 (en) * 2008-07-16 2010-01-21 Zimmer, Inc. Thermally treated ceramic coating for implants
WO2010028060A1 (en) * 2008-09-02 2010-03-11 Zimmer, Inc. Method for enhancing fretting fatigue resistance of alloys
US20100051141A1 (en) * 2008-09-02 2010-03-04 Zimmer, Inc. Method for enhancing fretting fatigue resistance of alloys
EP2204198A1 (en) * 2008-12-30 2010-07-07 Sandvik Intellectual Property AB Designed surfaces for use in medical implants or instruments
US9012043B2 (en) 2008-12-30 2015-04-21 Sandvik Intellectual Property Ab Designed surfaces for use in medical implants or instruments
WO2010077204A1 (en) * 2008-12-30 2010-07-08 Sandvik Intellectual Property Ab Designed surfaces for use in medical implants or instruments
US8663359B2 (en) 2009-06-26 2014-03-04 Dimicron, Inc. Thick sintered polycrystalline diamond and sintered jewelry
US20110146348A1 (en) * 2009-06-26 2011-06-23 Harding David P Thick sintered polycrystalline diamond and sintered jewelry
US9820539B2 (en) 2009-06-26 2017-11-21 Dimicron, Inc. Thick sintered polycrystalline diamond and sintered jewelry
US20110004794A1 (en) * 2009-07-03 2011-01-06 Jeong-Hun Lee Semiconductor memory device
US20110033309A1 (en) * 2009-08-07 2011-02-10 Chia-Teh Chen Ceiling fan positioning structure for shielding a hanging portion of a ceiling fan
US8277505B1 (en) 2011-06-10 2012-10-02 Doty Keith L Devices for providing up to six-degrees of motion having kinematically-linked components and methods of use
US11020232B2 (en) * 2012-06-18 2021-06-01 DePuy Synthes Products, Inc. Dual modulus hip stem and method of making the same
US20150069111A1 (en) * 2012-06-18 2015-03-12 DePuy Synthes Products, LLC Dual modulus hip stem and method of making the same
US10070959B2 (en) 2016-09-28 2018-09-11 DePuy Synthes Products, Inc. Method of texturing prosthetic implants
US10828168B2 (en) 2017-05-10 2020-11-10 Howmedica Osteonics Corp. Patient specific composite knee replacement
CN114831780A (en) * 2022-03-25 2022-08-02 四川大学华西医院 Cobalt alloy bone trabecula femur condyle prosthesis containing nitride layer and preparation method thereof
CN115161516A (en) * 2022-07-18 2022-10-11 嘉兴数字三维智能制造研究院有限公司 Cobalt-chromium alloy powder material special for dentistry

Similar Documents

Publication Publication Date Title
US5308412A (en) Method of surface hardening cobalt-chromium based alloys for orthopedic implant devices
US5192323A (en) Method of surface hardening orthopedic implant devices
AU646898B2 (en) Method of surface hardening orthopedic implant devices
US11351031B2 (en) Applications of diffusion hardening techniques
US20200197564A1 (en) Diffusion-hardened medical implant
US20130304219A1 (en) Surface treatment of co-cr based alloys using plasma carburization
CA2284816C (en) Method of surface oxidizing zirconium alloys and resulting product
AU2007200034B2 (en) Method for fabricating a medical implant component and such component
JP2006102500A (en) Boron-added medical implant and production method therefor
Torregrosa et al. Phase analysis, microhardness and tribological behaviour of Ti-6Al-4V after ion implantation of nitrogen in connection with its application for hip-joint prosthesis
Pohrelyuk et al. Increasing of functionality of cp titanium/UHMWPE tribo-pairs by thermodiffusion nitriding of titanium component
US20170367827A1 (en) Medical implants with 100% subsurface boron carbide diffusion layer
RU2338811C1 (en) Method of production of items out of titanium alloys and items produced by this method (versions)
AU2007200033B2 (en) Method for fabricating a medical implant component and such component
Greenwald et al. MOCVD of yttria stabilized zirconia on Co-Cr
Nutt Surface treatment for implants
JPH11206872A (en) In vivo sliding member and its manufacture

Legal Events

Date Code Title Description
AS Assignment

Owner name: ZIMMER, INC., INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:SHETTY, H. RAVINDRANATH;OTTERSBERG, WALTER H.;REEL/FRAME:006473/0118

Effective date: 19930305

STPP Information on status: patent application and granting procedure in general

Free format text: APPLICATION UNDERGOING PREEXAM PROCESSING

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: ZIMMER, INC., INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRISTOL-MYERS SQUIBB COMPANY;REEL/FRAME:012729/0494

Effective date: 20020114

AS Assignment

Owner name: ZIMMER TECHNOLOGY, INC., ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ZIMMER, INC.;REEL/FRAME:013862/0766

Effective date: 20020628

FPAY Fee payment

Year of fee payment: 12